| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $117.2M | — | +26.0% |
| Cost of Revenue | $31.9M | — | +33.4% |
| Gross Profit | $85.4M | — | +23.4% |
| R&D Expense | $13.8M | — | +8.4% |
| SG&A Expense | $16.9M | — | -9.6% |
| Operating Income | $12.7M | — | +287.2% |
| Pre-tax Income | $16.5M | — | +239.4% |
| Income Tax | $1.3M | — | -1.5% |
| Net Income | $15.3M | — | +343.3% |
| EPS (Basic) | $0.07 | — | +250.0% |
| EPS (Diluted) | $0.07 | — | +250.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $444.1M | -7.7% | +26.4% |
| Accounts Receivable | $100.4M | -19.4% | +25.3% |
| Current Assets | $562.2M | -10.1% | +25.9% |
| Total Assets | $734.2M | -7.0% | +22.6% |
| Current Liabilities | $260.3M | -4.9% | +25.0% |
| Total Liabilities | $295.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $24.3M | — | +4801.0% |
| Capital Expenditures | $1.3M | — | -15.7% |
| Investing Cash Flow | -$1.6M | — | +90.5% |
| Financing Cash Flow | -$58.9M | — | -177.3% |
| Free Cash Flow | $23.0M | — | +2355.4% |
| +24.4% |
| Stockholders' Equity | $438.8M | -8.3% | +21.4% |